Amer Zeidan: Outstanding panel discussions on all aspects of MDSsm in IACH COMyDAL meeting.

Amer Zeidan, shared on X/Twitter:

“Outstanding panel discussions on all aspects of MDSsm in IACH COMyDAL meeting. What a true pleasure to co-chair the meeting with the one and only Dr Valeria Santini and have such amazing faculty join us for very robust discussions & debates on how to move the field forward.”

Source: Amer Zeidan/Twitter

Amer Zeidan is an Associate Professor of Medicine (Hematology) at Yale University. He is also the medical director of Hematology Early Therapeutics Research, the leader of the Myeloid Malignancies DART (Disease Aligned Research Team), and the director of Continuing Medical Education (CME) at the Hematology division and chairs the Protocol Review Committee (PRC) at Yale Cancer Center. Dr. Zeidan is a well-known leukemia researcher with a special focus on targeted therapies and immunotherapy for myeloid malignancies, and a social media influencer in the field of blood cancer.